Diana Barb

Associate Professor

University of Florida

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Diana Barb is an Associate Professor at the University of Florida, USA. Her research focuses on metabolic dysfunction-associated liver diseases, including the role of GLP-1 treatments and the implications of obesity on liver health. She also investigates clinician and patient feedback related to shared decision-making tools in the evaluation of thyroid nodules.

Articles (10)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Collaborators (7)

David Kleiner

National Cancer Institute

UNITED STATES

View details

Sangeeta Kashyap

Assistant Chief of Clinical Affairs

NewYork-Presbyterian Hospital/Weill Cornell Medical Center

UNITED STATES

View details

Sanaa Badour

University of Florida

UNITED STATES

View details

Manal Abdelmalek

Professor of Medicine, Director MASLD Clinical Research

Mayo Clinic

UNITED STATES

View details

Fernando Bril

The University of Alabama

UNITED STATES

View details

Marialena Mouzaki

UNITED STATES

View details

Carma L. Bylund

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Diana Barb

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Plain language summary about GLP-1 treatments in people with metabolic dysfunction-associated steatotic liver disease

Clinician feedback using a shared decision-making tool for the evaluation of patients with thyroid nodules—an observational study

Obesity increases the risk of hepatic fibrosis in young adults with type 2 diabetes mellitus: the need to screen

The Emerging Role of Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis

Adipose Tissue Insulin Resistance Predicts the Severity of Liver Fibrosis in Patients With Type 2 Diabetes and NAFLD

AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease

Body Fat Distribution in Lean Individuals with Metabolic Abnormalities

Patient feedback receiving care using a shared decision making tool for thyroid nodule evaluation—an observational study

American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings: Co-Sponsored by the American Association for the Study of Liver Diseases (AASLD)

Development and pilot testing of a conversation aid to support the evaluation of patients with thyroid nodules

Collaborators (7)

David Kleiner

Sangeeta Kashyap

Sanaa Badour

Manal Abdelmalek

Fernando Bril

Marialena Mouzaki

Carma L. Bylund

Make your next move.